Home › Ischemic Stroke › Tennessee › Chattanooga
Ischemic Stroke clinical trials in Chattanooga, TN
4 studies for Ischemic Stroke are looking for participants at sites in and around Chattanooga (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
RecruitingPhase 2/3
- Corxel Investigational Site, Chattanooga
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
RecruitingPhase 3
- CHI Memorial Neuroscience Institute, Chattanooga
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
RecruitingPhase 2/3
- Erlanger Hospital, Chattanooga
- Chattanooga Center for Neurologic Research, Chattanooga
Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation
Recruiting
- Erlanger Medical Center, Chattanooga
About Ischemic Stroke
A stroke is a medical emergency that should be treated immediately. Read about the causes, symptoms and treatments for an ischemic stroke.
More about Ischemic Stroke on MedlinePlus
Ischemic Stroke trials in other cities
- New York City, NY18 studies
- Houston, TX18 studies
- Boston, MA17 studies
- Los Angeles, CA14 studies
- Philadelphia, PA13 studies
- Atlanta, GA13 studies
- Chicago, IL12 studies
- Baltimore, MD11 studies
- Pittsburgh, PA11 studies
- Cincinnati, OH11 studies
- St. Louis, MO11 studies
- Salt Lake City, UT10 studies
Other studies in Chattanooga
- Non-Small Cell Lung Cancer11 studies
- Myasthenia Gravis6 studies
- Metastatic Cancer6 studies
- Ovarian Cancer5 studies
- Steatotic Liver Disease4 studies
- Chronic Kidney Disease4 studies
- Lung Cancer4 studies
- Melanoma4 studies
- Diabetes4 studies
- Colorectal Cancer4 studies
- COPD3 studies
- Endometrial Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.